| BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis |
Globe Newswire |
08/27 |
01:00 |
| AP Pros Face Growing Layoff Concerns and See Automation as a Career Lifeline |
Globe Newswire |
08/26 |
10:16 |
| Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight |
Globe Newswire |
08/25 |
15:00 |
| Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025 |
Globe Newswire |
08/25 |
08:00 |
| Order.co Named ‘AI Procurement Software of the Year 2025’ by CIOReview for Smart Sourcing and Fulfillment Innovation |
Globe Newswire |
08/21 |
14:22 |
| Oilfield Chemicals Market Size to Surpass USD 50.24 Billion by 2034 Driven by Energy Demand and Sustainable Solutions |
Globe Newswire |
08/21 |
06:23 |
| Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates |
Globe Newswire |
08/20 |
19:57 |
| QIDI Q2 Launches: Redefining Your First Entry-Level 3D Printer |
Globe Newswire |
08/20 |
09:00 |
| Epiq and IRIS Partner to Deliver AI Document Capture and Management |
Globe Newswire |
08/19 |
08:00 |
| European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors |
Globe Newswire |
08/18 |
09:10 |
| Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA |
Globe Newswire |
08/17 |
19:30 |
| Stemly Tutoring Expands Expert AP Physics 1 Tutoring to Help Students Boost Exam Scores and Confidence |
Globe Newswire |
08/15 |
14:50 |